145 related articles for article (PubMed ID: 21044141)
1. Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus.
Matsumoto T; Yamada K; Noguchi K; Nakajima K; Takada K; Khawplod P; Nishizono A
Microbiol Immunol; 2010 Nov; 54(11):673-83. PubMed ID: 21044141
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein.
Sun L; Chen Z; Yu L; Wei J; Li C; Jin J; Shen X; Lv X; Tang Q; Li D; Liang M
Appl Microbiol Biotechnol; 2012 Oct; 96(2):357-66. PubMed ID: 22678022
[TBL] [Abstract][Full Text] [Related]
3. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ
Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135
[TBL] [Abstract][Full Text] [Related]
4. Novel monoclonal antibodies that bind to wild and fixed rabies virus strains.
Zanluca C; Aires LR; Mueller PP; Santos VV; Carrieri ML; Pinto AR; Zanetti CR
J Virol Methods; 2011 Jul; 175(1):66-73. PubMed ID: 21536074
[TBL] [Abstract][Full Text] [Related]
5. Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.
Bakker AB; Marissen WE; Kramer RA; Rice AB; Weldon WC; Niezgoda M; Hanlon CA; Thijsse S; Backus HH; de Kruif J; Dietzschold B; Rupprecht CE; Goudsmit J
J Virol; 2005 Jul; 79(14):9062-8. PubMed ID: 15994800
[TBL] [Abstract][Full Text] [Related]
6. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies.
Wiktor TJ; Macfarlan RI; Foggin CM; Koprowski H
Dev Biol Stand; 1984; 57():199-211. PubMed ID: 6526138
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates.
Sloan SE; Hanlon C; Weldon W; Niezgoda M; Blanton J; Self J; Rowley KJ; Mandell RB; Babcock GJ; Thomas WD; Rupprecht CE; Ambrosino DM
Vaccine; 2007 Apr; 25(15):2800-10. PubMed ID: 17240489
[TBL] [Abstract][Full Text] [Related]
8. [Development of Recombinant Human Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis].
Sun L; Liu Y; Li C; Li D; Liang M
Bing Du Xue Bao; 2016 Jul; 32(4):399-403. PubMed ID: 29979531
[TBL] [Abstract][Full Text] [Related]
9. Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment.
Papaneri AB; Wirblich C; Marissen WE; Schnell MJ
Vaccine; 2013 Dec; 31(49):5897-902. PubMed ID: 24120673
[TBL] [Abstract][Full Text] [Related]
10. Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies.
Prosniak M; Faber M; Hanlon CA; Rupprecht CE; Hooper DC; Dietzschold B
J Infect Dis; 2003 Jul; 188(1):53-6. PubMed ID: 12825170
[TBL] [Abstract][Full Text] [Related]
11. Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, RG719.
Ni Y; Tominaga Y; Honda Y; Morimoto K; Sakamoto S; Kawai A
Microbiol Immunol; 1995; 39(9):693-702. PubMed ID: 8577283
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing.
Raux H; Coulon P; Lafay F; Flamand A
Virology; 1995 Jul; 210(2):400-8. PubMed ID: 7542418
[TBL] [Abstract][Full Text] [Related]
13. Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein.
Lafon M; Edelman L; Bouvet JP; Lafage M; Montchâtre E
J Gen Virol; 1990 Aug; 71 ( Pt 8)():1689-96. PubMed ID: 2391499
[TBL] [Abstract][Full Text] [Related]
14. [Construction and detection the bioactivity of human anti-rabies virus scdsFv].
Yang R; Yang S; Wang C; Gao Y; Shan H; Xia X
Wei Sheng Wu Xue Bao; 2011 Jan; 51(1):98-104. PubMed ID: 21465795
[TBL] [Abstract][Full Text] [Related]
15. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
Seroka D
Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a panel of anti-phosphoprotein monoclonal antibodies generated against the raccoon strain of rabies virus.
Nadin-Davis SA; Fehlner-Gardiner C; Sheen M; Wandeler AI
Virus Res; 2010 Sep; 152(1-2):126-36. PubMed ID: 20600390
[TBL] [Abstract][Full Text] [Related]
17. Rabbit anti-rabies immunoglobulins production and evaluation.
Liu X; Liu Q; Feng X; Tang Q; Wang Z; Li S; Feng Z; Zhu J; Guan X
Trop Biomed; 2011 Apr; 28(1):138-48. PubMed ID: 21602780
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of rabies virus neutralization.
Flamand A; Raux H; Gaudin Y; Ruigrok RW
Virology; 1993 May; 194(1):302-13. PubMed ID: 7683158
[TBL] [Abstract][Full Text] [Related]
19. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays.
Moore SM; Ricke TA; Davis RD; Briggs DJ
Biologicals; 2005 Dec; 33(4):269-76. PubMed ID: 16168666
[TBL] [Abstract][Full Text] [Related]
20. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.
Goudsmit J; Marissen WE; Weldon WC; Niezgoda M; Hanlon CA; Rice AB; Kruif Jd; Dietzschold B; Bakker AB; Rupprecht CE
J Infect Dis; 2006 Mar; 193(6):796-801. PubMed ID: 16479514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
